SCHEMBL8058495

SCHEMBL8058495

O=C(O)C(CCc1ccncc1)(c1ccccc1)[PH](=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.40
HTT P42858 2/20 0.40
ALPL P05186 1/20 0.40
ALPI P09923 1/20 0.40
ALPG P10696 1/20 0.40
CYP1A2 P05177 4/20 0.40
CYP3A4 P08684 4/20 0.40
CYP2D6 P10635 4/20 0.40
CYP2C9 P11712 4/20 0.40
CYP2C19 P33261 4/20 0.40
LMNA P02545 1/20 0.38
RAB9A P51151 1/20 0.38
CYP19A1 P11511 1/20 0.37
GPR52 Q9Y2T5 1/20 0.37
NPY5R Q15761 1/20 0.36
HIF1A Q16665 2/20 0.36
ALDH1A1 P00352 3/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8046670 0.85 KCNA5 (0.39) SMN1; SMN2HTTALPLALPIALPG
SCHEMBL8059121 0.85 FDPS (0.47) CYP1A2CYP3A4CYP2C9CYP2C19HIF1A
SCHEMBL7644315 0.79 GRM2 (0.44) SMN1; SMN2RAB9AMAPTTDP1
SCHEMBL8059183 0.79 CYP1A2 (0.47) SMN1; SMN2CYP1A2CYP3A4CYP2C19LMNA
SCHEMBL8059180 0.78 GRM2 (0.45) GPR52MAPT
SCHEMBL8046498 0.78 TBXAS1 (0.50) CYP1A2CYP3A4CYP2C9CYP2C19HIF1A
SCHEMBL8058443 0.77 TBXAS1 (0.52) CYP1A2CYP3A4CYP2C9CYP2C19HIF1A
SCHEMBL8058494 0.76 CYP2C19 (0.40) SMN1; SMN2CYP2C19LMNARAB9ATDP1
SCHEMBL8058455 0.73 CYP1A2 (0.56) CYP1A2CYP3A4CYP2C9CYP2C19HIF1A
SCHEMBL7633968 0.73 KIF11 (0.43) HTTCYP1A2CYP2D6CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6046180-A NAALADase inhibitors GUILFORD PHARMACEUTICALS INC. (US) 2000-04-04 US disclosed